Feature Story
As Cancer Tears Through Africa, Drug Makers Draw Up a Battle Plan
SATURDAY, October 7, 2017 (The New York Times) — NAIROBI, Kenya — In a remarkable initiative modeled on the campaign against AIDS in Africa, two major pharmaceutical companies, working with the American Cancer Society, will steeply discount the prices of cancer medicines in Africa.
SATURDAY, October 7, 2017 (The New York Times) — NAIROBI, Kenya — In a remarkable initiative modeled on the campaign against AIDS in Africa, two major pharmaceutical companies, working with the American Cancer Society, will steeply discount the prices of cancer medicines in Africa.
Under the new agreement, the companies — Pfizer, based in New York, and Cipla, based in Mumbai — have promised to charge rock-bottom prices for 16 common chemotherapy drugs. The deal, initially offered to a half-dozen countries, is expected to bring lifesaving treatment to tens of thousands who would otherwise die.
You might have also missed…
Researchers Predict a Quarter-Million New Cases of Breast Cancer in the U.S.
Oct. 6, The New York Times
Oct. 6, The New York Times
When it comes to cancer, here’s what you should sweat and here’s what you shouldn’t
Oct. 12, Los Angeles Times
Oct. 12, Los Angeles Times
Blood test may find liver cancer earlier, improve survival
Oct. 9, The San Diego Union-Tribune
Oct. 9, The San Diego Union-Tribune
Researchers reveal biomarker for guiding prostate cancer treatment
Oct. 12, Medical Xpress
Oct. 12, Medical Xpress
